We are live on ! Find out more
TCM

Towercrest Capital Management Portfolio holdings

AUM $642M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+3.68%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$547M
AUM Growth
+$18.9M
Cap. Flow
+$1.75M
Cap. Flow %
0.32%
Top 10 Hldgs %
46.25%
Holding
98
New
4
Increased
36
Reduced
21
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 2.84%
2 Communication Services 0.94%
3 Financials 0.49%
4 Healthcare 0.44%
5 Consumer Discretionary 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFI icon
26
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.05B
$9.46M 1.73%
182,845
+241
+0.1% +$12.4K
LQD icon
27
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$9.03M 1.65%
68,152
+1,053
+2% +$140K
SHYG icon
28
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
$8.87M 1.62%
195,721
-3,074
-2% -$139K
ITOT icon
29
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$8.51M 1.56%
79,506
+1,038
+1% +$108K
SPDW icon
30
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.2B
$7.72M 1.41%
211,533
+2,055
+1% +$75.6K
SPIB icon
31
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$7.09M 1.3%
196,234
-2,415
-1% -$87.5K
SPEM icon
32
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.2B
$6.38M 1.17%
153,818
+12,378
+9% +$529K
SCHD icon
33
Schwab US Dividend Equity ETF
SCHD
$103B
$4.3M 0.79%
159,657
+2,832
+2% +$73.6K
MSFT icon
34
Microsoft
MSFT
$3.45T
$3.13M 0.57%
9,304
+69
+0.7% +$22.4K
IBB icon
35
iShares Biotechnology ETF
IBB
$9.34B
$2.79M 0.51%
18,305
SPMD icon
36
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
$2.66M 0.49%
53,415
-1,318
-2% -$64.4K
SPSM icon
37
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$2.59M 0.47%
58,002
-902
-2% -$40.1K
DGRO icon
38
iShares Core Dividend Growth ETF
DGRO
$42.7B
$2.56M 0.47%
46,103
+585
+1% +$31.2K
QQQ icon
39
Invesco QQQ Trust
QQQ
$453B
$2.4M 0.44%
6,035
+30
+0.5% +$11.6K
META icon
40
Meta Platforms (Facebook)
META
$1.42T
$2.33M 0.43%
6,913
IWF icon
41
iShares Russell 1000 Growth ETF
IWF
$121B
$2.29M 0.42%
29,944
SCHG icon
42
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$2.17M 0.4%
105,968
-1,304
-1% -$26.1K
SPTM icon
43
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.6B
$2.12M 0.39%
36,278
-1,656
-4% -$93.7K
JPM icon
44
JPMorgan Chase
JPM
$935B
$1.59M 0.29%
10,048
SPYD icon
45
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
$1.56M 0.29%
37,158
-76
-0.2% -$3.1K
RSP icon
46
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$1.25M 0.23%
7,665
SCHO icon
47
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$1.08M 0.2%
42,348
+44
+0.1% +$1.12K
JNJ icon
48
Johnson & Johnson
JNJ
$618B
$1.04M 0.19%
6,103
-70
-1% -$11.5K
SHY icon
49
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$985K 0.18%
11,517
+39
+0.3% +$3.35K
VTI icon
50
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$933K 0.17%
3,863
-12
-0.3% -$2.83K

Similar funds

Towercrest Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Towercrest Capital Management held 98 positions worth $547M, up 3.6% from $528M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Towercrest Capital Management's Q4 2021 filing shows 4 new, 36 increased, 21 reduced and 4 closed positions. Its largest new stake was NVIDIA: 7,890 shares worth $232K. The largest sale was Impel Pharmaceuticals Inc. Common Stock, an estimated $615K.

By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 2.4% a quarter earlier, followed by Communication Services and Financials.

  • Towercrest Capital Management's largest Q4 2021 buy was NVIDIA: 7,890 shares worth $232K.
  • Towercrest Capital Management added most to Schwab Emerging Markets Equity ETF in Q4 2021, an estimated $1.1M increase.
  • Towercrest Capital Management's biggest Q4 2021 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $466K.
  • Towercrest Capital Management fully exited Impel Pharmaceuticals Inc. Common Stock in Q4 2021, selling an estimated $615K.
  • Towercrest Capital Management's ten largest holdings make up 46% of its $547M portfolio in Q4 2021.
  • Towercrest Capital Management opened 4 new positions and closed 4 in Q4 2021.
  • Towercrest Capital Management's portfolio value rose 3.6% quarter-over-quarter to $547M.

Based on Towercrest Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.